Literature DB >> 10551885

High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL.

P Xia1, M A Vadas, K A Rye, P J Barter, J R Gamble.   

Abstract

The ability of high density lipoproteins (HDL) to inhibit cytokine-induced adhesion molecule expression has been demonstrated in their protective function against the development of atherosclerosis and associated coronary heart disease. A key event in atherogenesis is endothelial activation induced by a variety of stimuli such as tumor necrosis factor-alpha (TNF), resulting in the expression of various adhesion proteins. We have recently reported that sphingosine 1-phosphate, generated by sphingosine kinase activation, is a key molecule in mediating TNF-induced adhesion protein expression. We now show that HDL profoundly inhibit TNF-stimulated sphingosine kinase activity in endothelial cells resulting in a decrease in sphingosine 1-phosphate production and adhesion protein expression. HDL also reduced TNF-mediated activation of extracellular signal-regulated kinases and NF-kappaB signaling cascades. Furthermore, HDL enhanced the cellular levels of ceramide which in turn inhibits endothelial activation. Thus, the regulation of sphingolipid signaling in endothelial cells by HDL provides a novel insight into the mechanism of protection against atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551885     DOI: 10.1074/jbc.274.46.33143

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.

Authors:  Waleed Ahmed; Gabriela Orasanu; Vedika Nehra; Liana Asatryan; Daniel J Rader; Ouliana Ziouzenkova; Jorge Plutzky
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

Review 3.  New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.

Authors:  Philip J Barter; Rajesh Puranik; Kerry-Anne Rye
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

Review 4.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

5.  Detecting the functional complexities between high-density lipoprotein mimetics.

Authors:  Yoshitaka J Sei; Jungho Ahn; Taeyoung Kim; Eunjung Shin; Angel J Santiago-Lopez; Seung Soon Jang; Noo Li Jeon; Young C Jang; YongTae Kim
Journal:  Biomaterials       Date:  2018-04-06       Impact factor: 12.479

6.  Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.

Authors:  Enkhzol Malchinkhuu; Koichi Sato; Takeshi Muraki; Koichi Ishikawa; Atsushi Kuwabara; Fumikazu Okajima
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

7.  Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection Against Atherosclerosis in Hyperlipidemic Rabbits.

Authors:  Bradley K Wacker; Nagadhara Dronadula; Lianxiang Bi; Alexis Stamatikos; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-09       Impact factor: 8.311

8.  C(6)-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch-Injured Arteries.

Authors:  Sean M O'Neill; Dina K Olympia; Todd E Fox; J Tony Brown; Thomas C Stover; Kristy L Houck; Ronald Wilson; Peter Waybill; Mark Kozak; Steven W Levison; Norbert Weber; Linda M Karavodin; Mark Kester
Journal:  Vasc Dis Prev       Date:  2008-08-01

9.  Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL.

Authors:  Anny Mulya; Ji-Young Lee; Abraham K Gebre; Elena Y Boudyguina; Soon-Kyu Chung; Thomas L Smith; Perry L Colvin; Xian-Cheng Jiang; John S Parks
Journal:  J Lipid Res       Date:  2008-06-25       Impact factor: 5.922

Review 10.  The relationship between nutrition and prostate cancer: is more always better?

Authors:  Elizabeth M Masko; Emma H Allott; Stephen J Freedland
Journal:  Eur Urol       Date:  2012-11-15       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.